JLE

Epileptic Disorders

MENU

Clinical and electrographic features of persistent seizures and status epilepticus associated with anti-NMDA receptor encephalitis (anti-NMDARE) Volume 22, numéro 6, December 2020

  • [Armangue et al., 2013] Armangue T., Titulaer M.J., Malaga I. Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients. J Pediatr. 2013;162:850-6.e2. 4
  • [Baykan et al., 2018] Baykan B., Gungor Tuncer O., Vanli-Yavuz E.N. Delta brush pattern is not unique to NMDAR encephalitis: evaluation of two independent long-term EEG cohorts. Clin EEG Neurosci. 2018;49:278-284. 4
  • [Baysal-Kirac et al., 2016] Baysal-Kirac L., Tuzun E., Altindag E. Are there any specific EEG findings in autoimmune epilepsies? Clin EEG Neurosci. 2016;47:224-234. 3
  • [Begley et al., 2009] Begley C.E., Basu R., Reynolds T. Sociodemographic disparities in epilepsy care: results from the Houston/New York City health care use and outcomes study. Epilepsia. 2009;50:1040-1050. 5
  • [Burneo et al., 2009] Burneo J.G., Jette N., Theodore W. Disparities in epilepsy: report of a systematic review by the North American Commission of the International League Against Epilepsy. Epilepsia. 2009;50:2285-2295. 10
  • [Burgos et al., 2011] Burgos P.I., McGwin G.J., Pons-Estel G.J., Reveille J.D., Alarcon G.S., Vila L.M. US patients of Hispanic and African ancestry develop lupus nephritis early in the disease course: data from LUMINA, a multiethnic US cohort (LUMINA LXXIV). Ann Rheum Dis. 2011;70:393-394. 2
  • [Cohen et al., 2019] Cohen J., Sotoca J., Gandhi S. Autoimmune encephalitis: a costly condition. Neurology. 2019;92:e964-e972. 9
  • [Contreras et al., 2006] Contreras G., Lenz O., Pardo V. Outcomes in African Americans and Hispanics with lupus nephritis. Kidney Int. 2006;69:1846-1855. 10
  • [Cooray et al., 2015] Cooray G.K., Sengupta B., Douglas P., Englund M., Wickstrom R., Friston K. Characterising seizures in anti-NMDA-receptor encephalitis with dynamic causal modelling. Neuroimage. 2015;118:508-519.
  • [Dalmau et al., 2007] Dalmau J., Tuzun E., Wu H. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61:25-36. 1
  • [Dalmau et al., 2008] Dalmau J., Gleichman A.J., Hughes E.G. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7:1091-1098. 12
  • [Dalmau et al., 2011] Dalmau J., Lancaster E., Martinez-Hernandez E., Rosenfeld M.R., Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10:63-74. 1
  • [de Bruijn et al., 2019] de Bruijn M.A.A.M., van Sonderen A., van Coevorden-Hameete M.H. Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis. Neurology. 2019;92:e2185-e2196. 19
  • [England et al., 2012] England M.J., Liverman C.T., Schultz A.M., Strawbridge L.M. Epilepsy across the spectrum: promoting health and understanding. A summary of the Institute of Medicine report. Epilepsy Behav. 2012;25:266-276. 2
  • [Fisher et al., 2017a] Fisher R.S., Cross J.H., D'Souza C. Instruction manual for the ILAE 2017 operational classification of seizure types. Epilepsia. 2017;31:282-295. 4
  • [Fisher et al., 2017b] Fisher R.S., Cross J.H., French J.A. Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;31:272-281. 4
  • [Foff et al., 2017] Foff E.P., Taplinger D., Suski J., Lopes M.B.S., Quigg M. EEG findings may serve as a potential biomarker for anti-NMDA receptor encephalitis. Clin EEG Neurosci. 2017;48:48-53. 1
  • [Gillinder et al., 2019] Gillinder L., Warren N., Hartel G., Dionisio S., O’Gorman C. EEG findings in NMDA encephalitis: a systematic review. Seizure. 2019;65:20-24.
  • [Gordon-Lipkin et al., 2017] Gordon-Lipkin E., Yeshokumar A.K., Saylor D., Arenivas A., Probasco J.C. Comparative outcomes in children and adults with anti-N-methyl-D-aspartate (anti-NMDA) receptor encephalitis. J Child Neurol. 2017;32:930-935. 11
  • [Graus et al., 2016] Graus F., Titulaer M.J., Balu R. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15:391-404. 4
  • [Grinspan et al., 2015] Grinspan Z.M., Shapiro J.S., Abramson E.L., Hooker G., Kaushal R., Kern L.M. Predicting frequent ED use by people with epilepsy with health information exchange data. Neurology. 2015;85:1031-1038. 12
  • [Haberlandt et al., 2017] Haberlandt E., Ensslen M., Gruber-Sedlmayr U. Epileptic phenotypes, electroclinical features and clinical characteristics in 17 children with anti-NMDAR encephalitis. Eur J Paediatr Neurol. 2017;21:457-464. 3
  • [Jeannin-Mayer et al., 2019] Jeannin-Mayer S., André-Obadia N., Rosenberg S. EEG analysis in anti-NMDA receptor encephalitis: description of typical patterns. Clin Neurophysiol. 2019;130:289-296. 2
  • [Kelvin et al., 2007] Kelvin E.A., Hesdorffer D.C., Bagiella E. Prevalence of self-reported epilepsy in a multiracial and multiethnic community in New York City. Epilepsy Res. 2007;77:141-150. 2-3
  • [Leypoldt and Wandinger, 2014] Leypoldt F., Wandinger K.-P. Paraneoplastic neurological syndromes. Clin Exp Immunol. 2014;175:336-348. 3
  • [Liu et al., 2017] Liu X., Yan B., Wang R. Seizure outcomes in patients with anti-NMDAR encephalitis: a follow-up study. Epilepsia. 2017;58:2104-2111. 12
  • [Mohammad et al., 2016] Mohammad S.S., Soe S.M., Pillai S.C. Etiological associations and outcome predictors of acute electroencephalography in childhood encephalitis. Clin Neurophysiol. 2016;127:3217-3224. 10
  • [Price et al., 2015] Price P., Kobau R., Buelow J., Austin J., Lowenberg K. Improving understanding, promoting social inclusion, and fostering empowerment related to epilepsy: Epilepsy Foundation public awareness campaigns-2001 through 2013. Epilepsy Behav. 2015;44:239-244.
  • [Schmitt et al., 2012] Schmitt S.E., Pargeon K., Frechette E.S., Hirsch L.J., Dalmau J., Friedman D. Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology. 2012;79:1094-1100. 11
  • [Sonderen et al., 2018] Sonderen A., van, Arends S., Tavy D.L.J. Predictive value of electroencephalography in anti-NMDA receptor encephalitis. J Neurol Neurosurg Psychiatry. 2018;89:1101-1106. 10
  • [Spatola and Dalmau, 2017] Spatola M., Dalmau J. Seizures and risk of epilepsy in autoimmune and other inflammatory encephalitis. Curr Opin Neurol. 2017;30:345-353. 3
  • [Titulaer et al., 2013] Titulaer M.J., McCracken L., Gabilondo I. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12:157-165. 2
  • [Trinka et al., 2015] Trinka E., Cock H., Hesdorffer D. A definition and classification of status epilepticus: report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015;56:1515-1523. 10
  • [Viaccoz et al., 2014] Viaccoz A., Desestret V., Ducray F. Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis. Neurology. 2014;82:556-563. 7
  • [Veciana et al., 2015] Veciana M., Becerra J.L., Fossas P. EEG extreme delta brush: an ictal pattern in patients with anti-NMDA receptor encephalitis. Epilepsy Behav. 2015;49:280-285.
  • [Yeshokumar et al., 2017] Yeshokumar A.K., Gordon-Lipkin E., Arenivas A. Neurobehavioral outcomes in autoimmune encephalitis. J Neuroimmunol. 2017;312:8-14.
  • [Yildirim et al., 2018] Yildirim M., Konuskan B., Yalnizoglu D., Topaloglu H., Erol I., Anlar B. Electroencephalographic findings in anti-N-methyl-D-aspartate receptor encephalitis in children: a series of 12 patients. Epilepsy Behav. 2018;78:118-123.
  • [Zhang et al., 2017] Zhang Y., Liu G., Jiang M., Di, Li L.P., Su Y.Y. Analysis of electroencephalogram characteristics of anti-NMDA receptor encephalitis patients in China. Clin Neurophysiol. 2017;128:1227-1233. 7